By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


KineMed, Inc. 

5980 Horton Street, Suite 470

Emeryville  California  94608  U.S.A.
Phone: 510-655-6525 Fax: 510-655-6506



Company News
KineMed, Inc. Announces License Agreement To Develop Late-Stage Synthetic Ghrelin 9/24/2015 11:29:27 AM
KineMed, Inc. To Present At The Rodman & Renshaw 17th Annual Global Investment Conference 9/2/2015 7:43:23 AM
KineMed, Inc. And Pronutria Biosciences Enter Into Research And Development Collaboration 6/2/2015 11:31:42 AM
KineMed, Inc. And Camino Partnership Announce Collaboration To Create Portfolio Of Clinical Drug Candidates 4/23/2015 10:20:44 AM
KineMed, Inc. To Present “Capturing Value By De-Risking And Advancing Therapeutics” At The 17th Annual BIO CEO & Investor Conference 2/9/2015 11:08:59 AM
KineMed, Inc. Biomarker Studies In Chronic Lymphocytic Leukemia Reveal Groundbreaking Approach For Guiding Patient Management And Drug Development 11/18/2014 12:25:10 PM
KineMed, Inc. Receives Grant To Apply Novel Method For Measuring Muscle Mass In Infants And Children For The Diagnosis And Prevention Of Malnutrition And Growth Stunting 11/4/2014 10:41:59 AM
KineMed, Inc. And US Army Announce Collaboration To Measure Muscle Function And Response During Military Operations 10/28/2014 9:55:09 AM
KineMed, Inc. To Showcase Advances In Dynamic Proteomic Markers Of Neurodegenerative Disease At The 8th Annual Neurodegenerative Conditions Research & Development Conference 9/17/2014 10:05:12 AM
KineMed, Inc. Receives U.S. Patent Allowance For Noscapine To Treat ALS, Parkinson’s Disease, And Diabetic Neuropathy 9/4/2014 11:00:14 AM